TWP
PFE icon

Tyche Wealth Partners’s Pfizer PFE Stock Holding History

Tyche Wealth Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$518K Buy
21,503
+2,024
+10% +$52.9K 0.07% 187
2026
Q1 		$547K Sell
19,479
-1,615
-8% -$43K 0.08% 176
2025
Q4 		$525K Buy
21,094
+344
+2% +$8.68K 0.08% 186
2025
Q3 		$529K Sell
20,750
-4,127
-17% -$102K 0.09% 159
2025
Q2 		$603K Sell
24,877
-954
-4% -$22.2K 0.12% 137
2025
Q1 		$655K Sell
25,831
-29
-0.1% -$759 0.14% 107
2024
Q4 		$686K Buy
25,860
+4,859
+23% +$132K 0.14% 115
2024
Q3 		$608K Sell
21,001
-86
-0.4% -$2.51K 0.14% 110
2024
Q2 		$590K Buy
21,087
+894
+4% +$24.6K 0.14% 112
2024
Q1 		$560K Sell
20,193
-1,286
-6% -$35.7K 0.14% 122
2023
Q4 		$618K Buy
+21,479
New +$649K 0.15% 124

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tyche Wealth Partners's PFE Position: Q2 2026 in Review

Tyche Wealth Partners increased its Pfizer (PFE) stake by 10% in Q2 2026, buying an estimated $52.9K and bringing the position to 21,503 shares worth $518K. The position accounts for 0.07% of the portfolio, ranked #187.

Tyche Wealth Partners first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $686K in Q4 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Tyche Wealth Partners held 21,503 shares of Pfizer worth $518K as of Q2 2026.
  • Tyche Wealth Partners bought 2,024 Pfizer shares in Q2 2026, an estimated $52.9K.
  • Pfizer made up 0.07% of Tyche Wealth Partners's portfolio in Q2 2026, its #187 holding.
  • Tyche Wealth Partners first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Tyche Wealth Partners's Pfizer position peaked at $686K in Q4 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tyche Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.